EvlaBio
Last verified 2026-05-02. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $27.0Mattributed |
|---|---|
| Latest round | seed, $22.7M, 2025-07-01attributed |
| Founded | 2023 |
| Headquarters | Basel |
| Industry | bio |
| Stage | seed |
| Website | evlabio.com |
Biotech developing monoclonal antibody therapy
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2025-07-01 | seed | $22.7M | undisclosed |
Detected tech stack
Cloudflare, Linkedin Insight Tag, Railway, Google Font API, Google Hosted Libraries, Facebook Pixel, jquery 3.5.1
Provenance
| Fact | Status | Basis |
|---|---|---|
| Seed, $22.7M | attributed | crunchbase named as publisher. No document URL on file. |
| Total raised $27.0M | attributed | crunchbase named as publisher. No document URL on file. |
| Company existence | self-reported | evlabio.com, read 2026-05-02 |
| Description | self-reported | evlabio.com, read 2026-05-02 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.